✦ LIBER ✦

329. The impact of gemcitabine plus S-1 combination therapy in patients with highly advanced or recurrent pancreatic and biliary tract cancers

✍ Scribed by Saigo, K.; Otsuki, K.; Hasegawa, M.; Maruyama, M.; Akutsu, N.; Aoyama, H.; Matsumoto, I.; Noguchi, H.; Asano, T.; Kitamura, H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter, phase II study of gemcitabi

✍ Takashi Sasaki; Hiroyuki Isayama; Yousuke Nakai; Yukiko Ito; Hirofumi Kogure; Os 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 169 KB

Long-term outcome of S-1 and cisplatin c

✍ Yoshihisa Sakaguchi; Akira Kabashima; Keishi Okita; Yasutomo Ojima; Shinji Yamam 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 165 KB

6596 POSTER A Randomized Phase II Study

✍ Sasaki, T.; Isayama, H.; Ito, Y.; Yasuda, I.; Toda, N.; Hanada, K.; Matsubara, S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Phase II study of combined chemotherapy

✍ Komatsu, Yoshito; Yuki, Satoshi; Sogabe, Susumu; Fukushima, Hiraku; Nakatsumi, H 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 104 KB

PCN30 THE COSTS OF TREATING PATIENTS WIT

✍ M Nuijten 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Phase I and pharmacokinetic study of the

✍ Ramesh K. Ramanathan; Marwan Fakih; Sridhar Mani; Melvin Deutsch; Raymond P. Per 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 403 KB